Hector Madariaga, MD FASN 🇲🇽
@hecmagsmd.bsky.social
Transplant kidney doc | Tufts Medical Center | Immigrant |
#NephJC #NSMC | Spicy food | #Mexicanfood Connoisseur | #heforshe
#NephJC #NSMC | Spicy food | #Mexicanfood Connoisseur | #heforshe
Reposted by Hector Madariaga, MD FASN 🇲🇽
T3d
Benefits may vary, and results in the general population on CV risk and mortality are still
controversial.
Overall, the results of recent studies have been mixed results. Different study populations,
end points and dosing may account for the lack of clarity. #NephJC
December 3, 2025 at 2:43 AM
T3d
Benefits may vary, and results in the general population on CV risk and mortality are still
controversial.
Overall, the results of recent studies have been mixed results. Different study populations,
end points and dosing may account for the lack of clarity. #NephJC
Reposted by Hector Madariaga, MD FASN 🇲🇽
1/10
Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC
Read the article 👇
www.nejm.org/doi/10....
Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC
Read the article 👇
www.nejm.org/doi/10....
November 20, 2025 at 12:34 AM
1/10
Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC
Read the article 👇
www.nejm.org/doi/10....
Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC
Read the article 👇
www.nejm.org/doi/10....
Reposted by Hector Madariaga, MD FASN 🇲🇽
New Trump EO increases fee from $1,000 to $100,000 per year for H1B visas?? Aimed at tech companies hiring cheaper trained people.
However, this is going to be extremely disruptive to residency training programs and hospitals. Hope someone clues him in.
However, this is going to be extremely disruptive to residency training programs and hospitals. Hope someone clues him in.
September 20, 2025 at 1:58 AM
New Trump EO increases fee from $1,000 to $100,000 per year for H1B visas?? Aimed at tech companies hiring cheaper trained people.
However, this is going to be extremely disruptive to residency training programs and hospitals. Hope someone clues him in.
However, this is going to be extremely disruptive to residency training programs and hospitals. Hope someone clues him in.
A response to the NYT article about organ donation, from Tom Mone, a former President and Chief Executive Officer of the OneLegacy OPO
sidandt.org/tom-mones-re...
sidandt.org/tom-mones-re...
Tom Mone's Response to the New York Times — Science in Donation and Transplant
sidandt.org
August 12, 2025 at 12:46 AM
A response to the NYT article about organ donation, from Tom Mone, a former President and Chief Executive Officer of the OneLegacy OPO
sidandt.org/tom-mones-re...
sidandt.org/tom-mones-re...
May 20, 2025 at 12:09 AM
My birthday wishlist… 🔥
May 2, 2025 at 9:34 PM
My birthday wishlist… 🔥
I recently attended the Student National Medical Association’s AMEC 2025 conference,where we engaged w/med students/residents to promote the field of nephrology,mentoring opportunities, educational programs & health policy initiatives. It was a pleasure to work with the ASN staff
April 22, 2025 at 2:50 AM
I recently attended the Student National Medical Association’s AMEC 2025 conference,where we engaged w/med students/residents to promote the field of nephrology,mentoring opportunities, educational programs & health policy initiatives. It was a pleasure to work with the ASN staff
Reposted by Hector Madariaga, MD FASN 🇲🇽
T1f: #NephJC
3-Year Survival Outcomes
Pts who continued metformin ≥6 months after reaching CKD stage 4 demonstrated significantly higher survival (70.3%; 95% CI, 67.9–72.8) compared to those who discontinued early (63.4%; 95% CI, 60.5–66.5)
💡6.9 percentage-point difference (95% CI, 3.2–10.6)
3-Year Survival Outcomes
Pts who continued metformin ≥6 months after reaching CKD stage 4 demonstrated significantly higher survival (70.3%; 95% CI, 67.9–72.8) compared to those who discontinued early (63.4%; 95% CI, 60.5–66.5)
💡6.9 percentage-point difference (95% CI, 3.2–10.6)
April 16, 2025 at 1:41 AM
T1f: #NephJC
3-Year Survival Outcomes
Pts who continued metformin ≥6 months after reaching CKD stage 4 demonstrated significantly higher survival (70.3%; 95% CI, 67.9–72.8) compared to those who discontinued early (63.4%; 95% CI, 60.5–66.5)
💡6.9 percentage-point difference (95% CI, 3.2–10.6)
3-Year Survival Outcomes
Pts who continued metformin ≥6 months after reaching CKD stage 4 demonstrated significantly higher survival (70.3%; 95% CI, 67.9–72.8) compared to those who discontinued early (63.4%; 95% CI, 60.5–66.5)
💡6.9 percentage-point difference (95% CI, 3.2–10.6)
Worried About the Stock Market? Here's Warren Buffett's Investing Advice for Getting Through It.
Worried About the Stock Market? Here's Warren Buffett's Investing Advice for Getting Through It.
Around 62% of U.S. investors are pessimistic about the next six months, according to an April 2025 survey from the American Association of Individual Investors -- the highest figure since March 2009. ...
finance.yahoo.com
April 9, 2025 at 12:05 AM
Worried About the Stock Market? Here's Warren Buffett's Investing Advice for Getting Through It.
Checking some Greek art at the Museum of Fine Arts in Boston, when suddenly…. Mr Bean?!
April 7, 2025 at 1:12 AM
Checking some Greek art at the Museum of Fine Arts in Boston, when suddenly…. Mr Bean?!
Sebastian’s Story: A Kidney Transplant and a Second Chance at Life
Sebastian’s Story: A Kidney Transplant and a Second Chance at Life
Sebastian is back to doing what he loves thanks to his sister’s lifesaving kidney donation.
www.tuftsmedicine.org
April 5, 2025 at 6:06 PM
Sebastian’s Story: A Kidney Transplant and a Second Chance at Life
How much milk foam is too much?
April 5, 2025 at 3:37 PM
How much milk foam is too much?
Reposted by Hector Madariaga, MD FASN 🇲🇽
Diabetic Kidney Disease (DKD) ca. 2025 from @elsevierconnect.bsky.social @annagaddy.bsky.social @hecmagsmd.bsky.social @doctorgates.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/39753456/
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/39753456/
April 5, 2025 at 1:35 AM
Diabetic Kidney Disease (DKD) ca. 2025 from @elsevierconnect.bsky.social @annagaddy.bsky.social @hecmagsmd.bsky.social @doctorgates.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/39753456/
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/39753456/
Today, I had the honor of participating in this amazing panel to talk about organ donation, particularly those barriers that affect the Hispanic community. It was a privilege to listen to my co-panelists share their stories about their journeys with organ donation
April 2, 2025 at 12:42 AM
Today, I had the honor of participating in this amazing panel to talk about organ donation, particularly those barriers that affect the Hispanic community. It was a privilege to listen to my co-panelists share their stories about their journeys with organ donation
The American Society of Transplantation (AST) stands in support of their members who face immigration challenges 🙌
March 30, 2025 at 12:01 AM
The American Society of Transplantation (AST) stands in support of their members who face immigration challenges 🙌
Subcutaneous Ofatumumab in Recurrent Focal Segmental Glomerulosclerosis Post Kidney Transplantation
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
March 29, 2025 at 10:45 PM
Subcutaneous Ofatumumab in Recurrent Focal Segmental Glomerulosclerosis Post Kidney Transplantation
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
So, what’s up with the all those blood clots found in NBA players.
Is it the NSAIDs mostly?
apnews.com/article/bloo...
Is it the NSAIDs mostly?
apnews.com/article/bloo...
What is deep vein thrombosis and why do so many athletes like Damian Lillard get blood clots?
Milwaukee Bucks guard Damian Lillard is likely out indefinitely because of deep vein thrombosis in his right calf.
apnews.com
March 29, 2025 at 5:06 PM
So, what’s up with the all those blood clots found in NBA players.
Is it the NSAIDs mostly?
apnews.com/article/bloo...
Is it the NSAIDs mostly?
apnews.com/article/bloo...
First time watching the ISU World Skating Champsionship in Boston, MA. Here’s the new champ: Alysa Liu 🇺🇸
#Figureskating #Worldfigure
#Figureskating #Worldfigure
March 29, 2025 at 4:45 PM
First time watching the ISU World Skating Champsionship in Boston, MA. Here’s the new champ: Alysa Liu 🇺🇸
#Figureskating #Worldfigure
#Figureskating #Worldfigure
Trends in Sex Disparities in Access to Kidney Transplantation: A Nationwide US Cohort Study
While disparities in waitlisting have decreased over time, significant inequities persist, particularly among older women and those with diabetes
www.ajkd.org/article/S027...
While disparities in waitlisting have decreased over time, significant inequities persist, particularly among older women and those with diabetes
www.ajkd.org/article/S027...
March 22, 2025 at 4:35 PM
Trends in Sex Disparities in Access to Kidney Transplantation: A Nationwide US Cohort Study
While disparities in waitlisting have decreased over time, significant inequities persist, particularly among older women and those with diabetes
www.ajkd.org/article/S027...
While disparities in waitlisting have decreased over time, significant inequities persist, particularly among older women and those with diabetes
www.ajkd.org/article/S027...
Reposted by Hector Madariaga, MD FASN 🇲🇽
According to people knowing more than I on the topic, p values cannot be used to measure confounding in exposed and non-exposed cohorts—even in observational studies
#NephJC
pmc.ncbi.nlm.nih.gov/articles/PMC...
#NephJC
pmc.ncbi.nlm.nih.gov/articles/PMC...
Who is in this study, anyway? Guidelines for a useful Table 1
Epidemiologic and clinical research papers often describe the study sample in the first table. If well-executed, this “Table 1” can illuminate potential threats to internal and external validity. Howe...
pmc.ncbi.nlm.nih.gov
February 26, 2025 at 2:43 AM
According to people knowing more than I on the topic, p values cannot be used to measure confounding in exposed and non-exposed cohorts—even in observational studies
#NephJC
pmc.ncbi.nlm.nih.gov/articles/PMC...
#NephJC
pmc.ncbi.nlm.nih.gov/articles/PMC...
Where is Aldo when you need him the most?!?! cc @annagaddy.bsky.social #NephJC
February 26, 2025 at 2:08 AM
Where is Aldo when you need him the most?!?! cc @annagaddy.bsky.social #NephJC
